Robust, Consistent Phase 3 Data and Real-World Evidence Outcomes Support ANX005 as Potential First Targeted Therapy for GBS; Pre-BLA Meeting...
Top-line data for REFOCUS-ALZ, the second Phase 3 study of simufilam in Alzheimer’s disease, expected late first-quarter/early second-quarter 2025License agreement...
BURLINGTON, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (Neuphoria or Company), ”), a clinical-stage biotechnology...
AI-Driven Insights to Be Integrated with Life Imaging FLA's Full-Body CT Scan Services Through Their Upcoming 200 Location Expansion DENVER...
Noom + HRTRx blends Noom’s proven behavior change program with HRT medication to achieve whole-person healthThe new offering builds on...
HALO™ Clarity Devices Successfully Shipped for First Phase of Clinical TrialsHOUSTON, TX, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology,...
BOSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights...
LAKELAND, Fla., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Alpha Bites has burst onto the men’s wellness scene as a game-changing...
LONDON, MADRID, and BOSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a Kyowa Kirin company, announced it has recently...
Daridorexant is a potential best-in-class treatment in the high-growth, dual orexin antagonist class of medicines treating sleep disorders, such as...
NuCalm Donates One-Year Membership to their Mobile App to Help Families Heal from the Trauma of Loss and Displacement WILMINGTON,...
PHILADELPHIA, Feb. 27, 2025 /PRNewswire/ -- The Children's Brain Tumor Network (CBTN) announces the addition of the Carson Leslie Foundation...
A new one-step fabrication method improves the design of flexible 3D microelectrode arrays for neural applications BUSAN, South Korea, Feb....
AUSTIN, Texas, Feb. 27, 2025 /PRNewswire/ -- EudaLife™ Magazine, the definitive guide for affluent professionals seeking to optimize health and...
New study leverages Precision’s Layer 7 Cortical Interface for high-resolution brain mapping during craniotomy proceduresNEW YORK, Feb. 27, 2025 (GLOBE...
PALO ALTO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Orbus Therapeutics, Inc., a private, late-stage biopharmaceutical company focused on the...
OXFORD, England, Feb. 27, 2025 /PRNewswire/ -- Brainomix, a pioneer in stroke AI imaging software and European market leader, has...
Two immersive future-focused days of programming in education and health, bringing together leading innovators, VCs, policymakers, researchers and entrepreneurs for...
Dual AI engines in SmartSpeed Precise SmartSpeed Precise pelvis clinical image SmartSpeed Precise knee clinical image SmartSpeed Precise sinus clinical...
Meeting addressed progress and strategic direction for company’s induced mesenchymal stem cell (iMSC) therapy programsCAMBRIDGE, Mass., Feb. 26, 2025 (GLOBE...